Schedule 13G ownership disclosure
OKYO PHARMA LTD
Common · CUSIP: G6724L116
Event date: 2025-06-30
- Filing-level shares
- 2,735,780.00
- Percent of class
- 7.3%
- Dauntless Investment Group, LLC
Shares: 2,735,780.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-25-000996
- Form type
- SCHEDULE 13G/A
- Filer
- Dauntless Investment Group, LLC
- CIK
- CIK 2044285
- Filed
- Aug 05, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership